Prospect of IL-2,IL-7,IL-15 and IL-21 for HIV immune-based therapy

Journal of Central South University (Medical Sciences)

Volumn 36, Issue 11, 2011, Pages 1037-1045

  Diallo, Mamadou ^a   Zheng, Yuhuang ^a   Chen, Xia ^a   He, Yan ^a   Zhou, Huaying ^a   Chen, Zi ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

chain cytokines; CD4; Human immunodeficiency virus; Pathogenesis

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 7; INTERLEUKIN DERIVATIVE;

ARTICLE; CD4+ T LYMPHOCYTE; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-7; INTERLEUKINS;

EID: 84555196641     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2011.11.002     Document Type: Article

References (47)

1. White L, Krishnan S, Strbo N, et al. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV)[J]. Blood, 2007,109(9) :3873-3880. (Pubitemid 46641739)
2. Overwijk W W, Schluns K S. Functions of gammaC cytokines in immune homeostasis: current and potential clinical applications[J]. Clin Immunol,2009,132(2):153-165.
3. Gu X X, Yue F Y, Kovacs C M, et al. The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergy[J]. PLoS One, 2007,2(3) :e300.
4. Brincks E L, Woodland D L. Novel roles for IL-15 in T cell survival[J]. Biol Rep, 2010, 2:67.
5. + T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1 [J]. J Leukoc Biol, 2009, 86 (5) :1191-1203.
6. Reier A, Mitsuyasu R T. Use of interleukin-2 in immunotherapy of human immunodeficiency virus infection [J]. Bio Drugs, 1998,10(3) :215-225. (Pubitemid 28439465)
7. Létoumeau S, Krieg C, Panlaleo G, et al. IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of Tcell subsets[J]. J Allergy Clin Immunol, 2009,123(4) :758-762.
8. Brandenburg S, Takahashi T, de la Rosa M, et al. IL-2 induces in vivo suppression by CD4 (+), CD25 (+), FoxP3 (+) regulatory T Cells[J]. Eur J Immunol, 2008,38(6) : 1643-1653.
9. Anaya J P, Sias J J. The use of interleukin-2 in human immunodeficiency vi brus infection [J]. Pharmacotherapy, 2005,25(1) :86-95. (Pubitemid 40054037)
10. Temesgen Z. Interleukin-2 for the treatment of human immunodeficiency virus infection [J]. Drugs Today (Bare), 2006,42 (12) :791-801.
11. Marchetti G, Franzetti F, Gori A. Partial immune reconstitution following highly active antiretroviral therapy : can adjuvant interleukin-2 fill the gap? [J]-J Antimicrob Chemother, 2005, 55 (4) : 401409.
12. Pett S L, Kelleher A D, Emery S. Role of interleukin-2 in patients with HIV infection [ J]. Drugs, 2010,70 (9); 1115-1130.
13. Freeden-Jeffry U, Vieira P, Lucian LA, et al. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundantcytokine[J]. J Exp Med, 1995,181 (4) :1519-1526.
14. Peschon J J, Morrissey P J, Grabstein K H, et al. Park early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice [ J ]. J Exp Med, 1994,180(5) : 1955-1960.
15. Schluns K S, Kieper W C, Jameson S C, et al. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo[J]. Nat Immunol, 2000,1 (5) : 426-432.
16. + T cells in lymphopenic hosts [J]. Immunity,1999,11(2) :183-190.
17. Sportes C, Hakim F T, Memon S A, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets[ J]. J Exp Med, 2008,205(7) : 1701-1714. (Pubitemid 351962032)
18. + gain on antiviral therapy[J]. PLoS One, 2010,5(12) :el5663.
19. Levy Y, Lacabaratz C, Weiss L, et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment[J]. J Clin Invest, 2009, 119(4) : 997-1007.
20. Chahroudi A, Silvestri G. Interleukin-7 in HIV pathogenesis and therapy[J]. Eur Cytokine Netw, 2010, 21(3) : 202-207.
21. + cells after antiretroviral therapy [J]. J Infect Dis, 2008,198(10):1466-1473.
22. Ahmad A, Ahmad R, Iannello A, et al. IL-15 and HIV infection:lessons for immunotherapy and vaccination [ J ]. Curr HIV Res, 2005,3(3) : 261-270. (Pubitemid 41052425)
23. Brincks E L, Woodland D L. Novel roles for IL-15 in T cell survival[J]. F1000 Biol Rep, 2010, 2:67.
24. DONG Jun,YANG Suxia,GAO Jiangping, et al. In vitro expansion of T cells stimulated by combination of IL-2, IL-7 and IL15 [J]. Journal of Experimental Hematology, 2010, 18(6):1590-1594.
25. Rodrigues L, Bonorino C. Role of IL-15 and IL-21 in viral immunity; applications for vaccines and therapies[J]. Expert Rev Vaccines, 2009, 8(2) : 167-177.
26. Mueller Y M, Katsikis P D. IL-15 in HIV infection; pathogenic or therapeutic potential? [J]. Eur Cytokine Netw,2010,21 (3);219-221.
27. d'Ettorre G, Forcina G, Lichtner M, et al. Interleukin-15 in HIV infection; immunological and virological interactions in antiretroviral-naive and -treated patients [J]. AIDS, 2002,16 (2):181-188. (Pubitemid 34118564)
28. Mueller Y M, Bojczuk P M, Halstead E S, et al. IL-15 enhances survival and function of HIV-specific CD8 + T Cells[J]. Blood, 2003,101(3) : 1024-1029. (Pubitemid 36139375)
29. Chehimi J, Marshall J D, Salvucci O, et al. IL-15 enhances immune functions during HIV infection[ J]. J Immunol, 1997, 158(12):5978-5987. (Pubitemid 127484007)
30. Ahmad R, Sindhu S T, Toma E, et al. Studies on the production of IL-15 in HIV-infected/AIDS patients[J]. J Clin Immunol, 2003,23(2) :81-90. (Pubitemid 36324198)
31. + T cell subsets[J]. Immunity, 2009,31 (5):811-822.
32. Oh S, Perera L P, Burke D S, et al. IL-15/IL-15 Ralpha-mediated avidity maturation of memory CD8+ T cells[J]. Proc Nail Acad Sei U S A.2004,101 (42) :15154-15159. (Pubitemid 39391734)
33. Kraynyak K A, Kutzler M A, Cisper N J, et al. Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo [J]. Hum Gene Ther,2009,20(10):1143-1156.
34. Lum J J, Schnepple D J, Nie Z, et al. Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunod-eficiency virus activity [J]. J Virol, 2004, 78 (11) :6033-6042. (Pubitemid 38661691)
35. Ozaki K, Kikly K, Michalovich D, et al. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain [J]. Proc Natl Acad Sci USA, 2000,97(21):1444.
36. Ariga T, Yamaguchi K, Yoshida J, et al. The role of common gamma chain in human monocytes in vivo; evaluation from the studies of X-linked severe combined immunodeficiency (XSCID) carriers and X-SCID patients who underwent cord blood stem cell transplantation [ J]. Br J Haematol, 2002,118(3):858-863. (Pubitemid 35007395)
37. + T-regulatory cells[ J]. J Immunolher,2006, 29(3) : 313-319.
38. Toomey J A, Gays F, Foster D, et al. Cytokine requirements for the growth and development of mouse NK cells in vitro[ J]. J Leukoc Biol, 2003,74(2) : 233-242. (Pubitemid 38040420)
39. Iannello A, Boulassel M R, Samarani S, et al. Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study[J]. J Immunol,2010, 184 (1):114-126.
40. Johnson L D S, Jameson S C A chronic need for IL-21 [J]. Science,2009, 324 (5934): 1525-1526.
41. + T cell function[J]. J Virol,2010, 85 (2) : 733-741.
42. Williams L D, Bansal A, Sabbaj S, et al. Interleukin-21-producing HIV-I-specific CD8 T cells are preferentially seen in elite controllers[J]. J Virol, 2011, 85(5) :2316-2324.
43. + T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control[J]. J Immunol, 2010,185(1):498-506.
44. Parmigiani A, Pallin M F, Schmidtmayerova H, et al. Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T Cells[J]. Hum Immunol, 2011,72(2) :115-123.
45. Fóbhlich A, Kisielow J, Schmitz I, et al. IL-21 R on T cells is critical ior sustained functionality and control of chronic viral infection[J]. Science, 2009,324(5934) : 1576-1580.
46. Chen X, Zheng Y, Li H, et al. The Vpr gene polymorphism of human immunodeficiency virus type 1 in China and its clinical significance[J], Curr HIV Res, 2011, 9(7) :295-299.
47. He M, Zheng Y, Zhou H, et al. Prospective observation for seven-year' s highly active antiretroviral therapy in Chinese HlVK-Il infected palientsf [J]. Curr HIV Res, 2011, 9(4): 160-165.